U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 28

Tests names and labsConditionsGenes, analytes, and microbesMethods

MVL Vision Panel

Molecular Vision Laboratory
United States
13581028
  • C Sequence analysis of the entire coding region

Congenital Myasthenic Syndrome Panel

PreventionGenetics, part of Exact Sciences
United States
5932
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Non-Immune Hydrops Fetalis Panel

PreventionGenetics, part of Exact Sciences
United States
291148
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Multiple pterygium syndrome, lethal type NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Multiple pterygium syndrome, lethal type Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Multiple pterygium syndrome, lethal type Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Myasthenic syndrome, congenital, 3A, slow-channel, 616321, Autosomal dominant; CMS3A (Congenital myasthenic syndrome) (CHRND gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Myasthenic syndrome, congenital, 3A, slow-channel, 616321, Autosomal dominant; CMS3A (Congenital myasthenic syndrome) (CHRND gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

NeuromuscularZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
480254
  • C Sequence analysis of the entire coding region

Multiple pterygium syndrome, lethal type NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Multiple pterygium syndrome, lethal type Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Multiple pterygium syndrome, lethal type Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
73
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Congenital Myasthenic Syndrome Panel

Invitae
United States
3821
  • D Deletion/duplication analysis

Invitae Comprehensive Neuromuscular Disorders Panel

Invitae
United States
353208
  • D Deletion/duplication analysis

Arthrogryposis panel. NGS panel of 69 genes.

Genologica Medica
Spain
13569
  • C Sequence analysis of the entire coding region

Complete panel of pulmonology. NGS panel of 66 genes.

Genologica Medica
Spain
11566
  • C Sequence analysis of the entire coding region

Congenital myasthenic syndromes panel. 18-gene NGS panel.

Genologica Medica
Spain
3818
  • C Sequence analysis of the entire coding region

Central hypoventilation and apnea panel. NGS panel of 15 genes.

Genologica Medica
Spain
3715
  • C Sequence analysis of the entire coding region

Skeletal diseases. NGS panel of 169 genes.

Genologica Medica
Spain
373169
  • C Sequence analysis of the entire coding region

Congenital Myasthenic Syndromes (NGS Panel and Copy Number Analysis)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
2622
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 28

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.